Business · Markets · 2 hrs ago
Swiss stocks set for firmer opening as earnings season approaches
Swiss stocks were expected to open higher on Monday, with pre-market trading putting the main SMI index up 0.38% at 13,840 points.
The forecast followed a 1.1% rise in the SMI on Friday.
The briefing linked the expected gain partly to a slight easing in bond markets.
Monday was expected to bring few major news items, but companies are due to start reporting third-quarter results during the week.
Roche said it would present annual Phase III data for its eye medicine Vamikibart.
The US Food and Drug Administration has accepted an application to approve the drug and is expected to decide by July 2027.
Investors will be watching the upcoming company results and the regulatory decision for updates on the Swiss market and Roche’s drug.
Swiss stocks were set to open firmer on Monday, according to pre-market prices.
The SMI was up 0.38% at 13,840 points before the market opened.
The expected rise followed a gain of 1.10% for the SMI on Friday.
The market briefing said the start of the week was light on news.
Third-quarter earnings reports were due to begin during the week.
- Who
- Swiss stocks, led by the SMI.
- What
- The market was set for a firmer opening.
- When
- Monday, October 12, 2026.
- Where
- Switzerland.
- Why
- Pre-market prices pointed higher, with some support from easing bond markets; third-quarter reporting was due to begin during the week.
This story does not have two clearly opposing sides.
No direct quotes in the coverage so far.
The SMI rose 1.10% to 13,787 points.
The SMI was up 0.38% at 13,840 points, indicating a firmer opening.
Third-quarter earnings reporting was due to begin.
- SMI pre-market
- 13,840 points, up 0.38%
- SMI on Friday
- 13,787 points, up 1.10%
- Earnings season
- Third-quarter reporting due to begin during the week
- Bond markets
- Slight easing cited as support for stocks








